ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitani, Y.
Right arrow Articles by Sakurai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitani, Y.
Right arrow Articles by Sakurai, M.
Eur Respir J 2001; 17:316-320
Copyright ©ERS Journals Ltd 2001


Vascular smooth muscle cell phenotypes in primary pulmonary hypertension

Y. Mitani1, M. Ueda2, R. Komatsu2, K. Maruyama3, R. Nagai4, M. Matsumura5 and M. Sakurai3

1 Dept of Pediatrics and 2 Dept of Anesthesiology, Mie University School of Medicine, Tsu, Mie, Japan. 3 Dept of Pathology, Osaka City University Medical School, Osaka, Japan. 4 Second Dept of Medicine, Gunma University School of Medicine, Gunma, Japan. 5 Dept of Pediatrics, Tenri Hospital, Nara, Japan

CORRESPONDENCE: M. Ueda, Dept of Pathology, Osaka City University Medical School, 1-4-3 Asahi-machi, Osaka, Japan. Fax: 81 666453742

Keywords: cytoskeletal proteins, fibronectin, intimal hyperplasia, macrophage, plexiform lesion

Received: January 13, 1999
Accepted July 18, 2000

Abstract

Primary pulmonary hypertension (PPH) is associated with specific structural alterations, including cellular intimal thickening, intimal fibrosis, and plexiform lesions.

To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies. Cells that stained positive (+) with HHF35, CGA7, anti-SM1, and anti-SM2 were considered to be SMCs of a mature state. Conversely, those that stained positive with HHF35 and anti-SM1, but weakly positive (+/–) or negative (–) with CGA7 and anti-SM2, were considered to be SMCs exhibiting an immature state.

Cellular intimal thickening was composed of SMCs of an immature phenotype (HHF35+, CGA7+/–, SM1+, SM2+/–), accompanied by the expression of fibronectin and the presence of macrophages; intimal fibrosis contained mature SMCs (HHF35+, CGA7+, SM1+, SM2+); and plexiform lesion consisted of proliferative endothelial cells (von Willebrand factor-positive cells, proliferating cell nuclear antigen-positive cells) and underlying immature SMCs (HHF35+, CGA7–, SM1+, SM2–) associated with fibronectin expression and macrophage infiltration.

These findings suggest that smooth muscle cells with specific phenotypes may contribute to the development of specific vascular lesions in primary pulmonary hypertension.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.